Montgomery County pushes $10B biotech 'science city'

A group of officials from Johns Hopkins University is joining forces with a group of biotech business leaders in the state to move ahead today with plans to build a $10 billion, 17.5 million-square-feet R&D "science city" in Maryland's Montgomery County. The county council is expected to endorse the ambitious project, which would go a long way toward making the county a biotech hub that could rival the likes of Palo Alto.

County Executive Isiah Leggett, meanwhile, is in Chicago to tout the area as a biotech leader at the annual meeting of BIO. And his delegation is being joined by chief executives from Human Genome Sciences and MedImmune, two big biotech players based in the county.

Some nearby residents are skeptical about the project, but the proposed R&D complex would neighbor a new set of buildings planned for the National Cancer Institute.

- read the story from the Washington Post

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.